CCL2 and chronic cystitis: Imatinib treatment via transurethral bladder infusion did not significantly affect CCL2, IL-6, BDNF, NGF, VEGFaa or VEGFab LP mRNA or urinary bladder protein expression in female mice with 4 h CYP cystitis (Figures 4, 5).